US Patent Issued to Merck Sharp & Dohme on April 21 for "Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses" (American, British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,369, issued on April 21, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses" was invented by Kira A. Armacost (Doylestown, Pa.), Andrew John Cooke (Scotland, Great Britain), Robert Patrick Hayes (Lexington, Mass.), Marc A. Labroli (Moorestown, N.J.), Michael Aaron Plotkin (Frenchtown, N.J.), Izzat Tiedje Raheem (Doylestown, Pa.), Jeffrey W. Schubert (North Wales, Pa.) and David M. Tellers (Lansdale, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel Amido-Substituted Heterocycle Compounds of Formula (I...